glp-1 and kidney receptor agonists are increasingly used to treat type 2 diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of failure. Adverse events are mostly gastrointestinal GLP-1 agonists in the treatment

Despite their benefits, access to GLP-1 medications remains inequitable

insurance coverage is much worse, Dr

GoodSense ClearLax Polyethylene Glycol 3350 Powder Osmotic Laxative - 17.9 oz | Miralax $19.99 GoodSense ClearLax Polyethylene Glycol 3350 Powder 17.9 oz (30 Doses) | Compare to MiraLAX Gentle, Predictable Relief for Occasional Constipation GoodSense ClearLax provides effective,... read more View Product Metamucil vs Miralax: Top GLP-1 Constipation Options Compared When analyzing what's the difference between Miralax and Metamucil , it all comes down to the mechanism of action

In previous studies, p53 TAD was shown to significantly influence the DNA selectivity of p53 DBD, with the acidic residues of TAD believed to contribute to this selectivity through interactions with the basic residues of DBD 54